You Can’t Buy Your Way Out of an American Death Sentence — Even When You’re Rich

(SeaPRwire) –   America spends nearly double what peer nations spend on health care per capita and yet its richest citizens expire months or even years earlier than their European counterparts. That is not a marginal gap. It is a structural failure dressed up as normal.

The central finding from Brown University’s analysis of over 73,000 adults aged fifty to eighty-five across the United States and sixteen European countries cuts straight through the usual deflections. Median household income in America hit a record $87,460 in 2025 according to September Census Bureau figures. Life expectancy reached seventy-nine years in 2024, also a new high. And still the wealthiest quartile of Americans experiences roughly a thirty-five percent higher mortality rate than the wealthiest people in northern and western Europe. Survival among America’s richest quartile maps directly onto the survival curve of the poorest quartile in France, Germany, and the Netherlands. The data was collected starting in 2010 and followed for approximately a decade using the U.S. Health and Retirement Study and Europe’s SHARE survey. Sara Machado, a research scientist at Brown’s Center for Health System Sustainability, noted plainly that even the wealthiest Americans do not outperform most of northern and western Europe. The narrative that you can buy your way out of premature death turns out to be fiction.

U.S. spending per person on health care reached an estimated fourteen thousand seven hundred seventy-five dollars in 2024. That is nearly seven thousand dollars more than the average comparable wealthy country. Those peer countries averaged a life expectancy of eighty-two point seven years, three point seven years longer than the United States. Yet about twenty-six point seven million Americans went entirely uninsured throughout 2025 based on Census data. Roughly two point six million fewer Americans held ACA marketplace plans in early 2026 than in early 2025. Health coverage remains tightly tethered to employment rather than guaranteed as a right. Inequality compounds the problem across both sides of the Atlantic but far more sharply in the United States. Irene Papanicolas, senior author of the study and a professor directing Brown’s Center for Health System Sustainability, observed that while wealth inequality narrows after age sixty-five across both the U.S. and Europe, the American convergence happens because the poorest Americans die sooner and in greater proportion. Lifestyle factors compound the divide. Heart disease and cancer remain the two leading causes of death nationally. Americans tend toward less healthy diets and more sedentary routines. Smoking and rural living appear at higher rates in the United States and correlate with poorer health outcomes. Higher American rates of avoidable deaths from firearms, alcohol, and suicide further widen the gap. Creative Planning CEO Peter Mallouk recently flagged the widening rich-poor divide in America as unsustainable. Southern Europe recorded death rates about thirty percent lower than the U.S. continental Europe showed reductions of roughly forty percent across the study period.

Recent gains in U.S. longevity arrived primarily from the tail end of the pandemic and a decline in overdose and suicide deaths during 2024 according to CDC reports. Those improvements have not meaningfully closed the transatlantic gap. Machado suggested individuals need to think deliberately about retirement timing and post-retirement happiness. Papanicolas pushed harder toward systemic understanding, emphasizing the need to examine underlying factors that produce different health outcomes across nations among similar socioeconomic groups. She stressed collectively shaped causes rather than individual blame alone. What Europe demonstrates is not simply better spending priorities. It is an architecture where universal access removes the catastrophic financial trigger that pushes Americans into delayed care, emergency-room dependency, and untreated chronic conditions until disease becomes terminal.

Europe also contains two recognized blue zones, Sardinia in Italy and Ikaria in Greece, where longevity researchers credit daily physical activity, Mediterranean diet patterns, structured rest, and dense social connection, though some scholars dispute those claims. Regardless of whether blue-zone mystique plays a measurable role, the structural advantage of universal systems remains empirically visible across the dataset. The gap is widest where health access depends on employer status and narrowest where it does not.

If the goal is reducing mortality among the richest Americans rather than only among the poor, the policy lever shifts from expanding safety-net programs alone toward restructuring primary-care access, prescription drug pricing, preventive-cardiology funding, and workplace-linked insurance portability. Fixing health outcomes is not merely a challenge reserved for the most vulnerable as Machado stated. The top wealth tier is affected too. Closing the lifespan gap will require treating the American system’s design flaws as the root cause rather than attributing premature death to individual lifestyle choices within a broken architecture.